Neuraxis (NRXS) Liabilities and Shareholders Equity (2022 - 2025)
Neuraxis (NRXS) recorded Liabilities and Shareholders Equity of $6.4 million in Q4 2025, up 34.6% from $4.76 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends
Starting with Q4 2022, Neuraxis' Liabilities and Shareholders Equity history includes 12 quarters.
- Annual Liabilities and Shareholders Equity has a three-year compound annual growth rate of 62.9% (FY2022 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $4.76 million in FY2024 (+833.8%), $509,498 in FY2023 (-65.6%) and $1.48 million in FY2022.
- Quarterly Liabilities and Shareholders Equity has ranged from $509,498 in Q4 2023 to $7.09 million in Q2 2025 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased for five consecutive quarters, with growth averaging 246.7% over the last seven quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 833.8% in Q4 2024, against a decline of 65.6% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.78 million (Q3 2025), $7.09 million (Q2 2025) and $3.03 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.17 Bn | 228.32 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 179.42 Bn | 150.51 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 161.98 Bn | 145.80 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 156.76 Bn | 137.18 Bn | 2.08 Bn | 19.35 Bn |
| 5 | Medtronic | 122.13 Bn | 88.00 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 117.84 Bn | 103.96 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 66.19 Bn | 61.20 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Becton Dickinson | 54.16 Bn | 51.31 Bn | 2.32 Bn | 50.73 Bn |
| 9 | Edwards Lifesciences | 51.35 Bn | 35.47 Bn | 1.35 Bn | 13.87 Bn |
| 10 | Neuraxis | 92.39 Mn | 67.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 5.78 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 945,729.00 |
| Dec 31, 2023 | 509,498.00 |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.48 Mn |
API Access
Neuraxis Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();